Trial intelligence / Profile preview

Intranasal Dexmedetomidine for Sedation in Upper GI Endoscopy

NCT01887184Phase 3Completed

Sponsor
The University of Hong Kong
Start
Jan 2009
Primary completion
Mar 2010
Modality
Small Molecules
01

Overview

Phase 3, randomised, double-blind trial in gastrointestinal disease comparing Dexmedetomidine with Placebo (2 arms). Primary endpoint: Consumption of Rescue Patient Controlled Propofol. Started Jan 2009; status: completed.

02

Drugs

dexmedetomidine
03

Conditions

gastrointestinal disease

Beyond the preview

Go deeper on NCT01887184.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01887184.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call